Last reviewed · How we verify

NCT06253728: COBRA

A Study of Biochemical Response to Alternative Proteins

Status unknown NA Last updated 12 February 2024
What this trial tests

NA trial testing High fiber and protein meal in Postprandial Hyperglycemia in 24 participants. Status unknown.

Timeline
18 January 2024
Primary endpoint
3 June 2024
31 December 2025

Quick facts

Lead sponsorUniversity of Eastern Finland
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposeprevention
Enrollment24
Start date18 January 2024
Primary completion3 June 2024
Estimated completion31 December 2025
Sites1 location across Finland

Drugs / interventions tested

Conditions studied

Sponsor

University of Eastern Finland

Who can join

Adults 30 to 65, any sex, with Postprandial Hyperglycemia or Overweight and Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall objective of this research is to determine the digestive faith and health impact of protein and fiber rich foods in different food matrices in type 2 diabetes risk population. This is achieved by controlled postprandial intervention where plasma amino acids, lipids, glucose metabolism, bile acids and microbial metabolites are evaluated as well as fecal microbiota and metabolites.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Postprandial Hyperglycemia

Currently open trials in the same condition.

Other University of Eastern Finland trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06253728.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing